Literature DB >> 28279483

Doxycycline: a first-line treatment for bullous pemphigoid?

Henry J Grantham1, Deborah D Stocken2, Nick J Reynolds3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28279483     DOI： 10.1016/S0140-6736(17)30549-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology.

Authors:  Ayman Grada; Mahmoud A Ghannoum; Christopher G Bunick
Journal:  Antibiotics (Basel)       Date:  2022-05-27

Review 2.  BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors:  Yale Liu; Liang Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

3.  Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

Authors:  Aniek Lamberts; H Ilona Euverman; Jorrit B Terra; Marcel F Jonkman; Barbara Horváth
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

Review 4.  Bullous pemphigoid.

Authors:  Denise Miyamoto; Claudia Giuli Santi; Valéria Aoki; Celina Wakisaka Maruta
Journal:  An Bras Dermatol       Date:  2019-05-09       Impact factor: 1.896
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.